Grace Therapeutics (GRCE) EBITDA (2011 - 2026)
Grace Therapeutics' EBITDA came in at -$2.29 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$2.53 million a year earlier.
Grace Therapeutics (GRCE) EBITDA (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Grace Therapeutics reported EBITDA of -$23.66 million; for FY2026 (ended Mar 31, 2026), it came in at -$11.07 million.
- Going back by fiscal year, EBITDA was -$16.67 million in FY2025, -$12.84 million in FY2024, -$52.03 million in FY2023 and -$15.59 million in FY2022.
- The fiscal Q2 2027 figure represents the highest quarterly EBITDA since fiscal Q2 2024.
- Business Quant data shows GRCE's EBITDA at -$15.92 million (Q1 2027), -$3.01 million (Q4 2026) and -$2.45 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | -2.29 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.29 Mn |
| Jun 30, 2026 | -15.92 Mn |
| Mar 31, 2026 | -3.01 Mn |
| Dec 31, 2025 | -2.45 Mn |
| Sep 30, 2025 | -2.53 Mn |
| Jun 30, 2025 | -3.09 Mn |
| Mar 31, 2025 | -3.18 Mn |
| Dec 31, 2024 | -3.70 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -4.96 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Dec 31, 2023 | -3.04 Mn |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -4.45 Mn |
| Mar 31, 2023 | -38.07 Mn |
| Dec 31, 2022 | -4.24 Mn |
| Sep 30, 2022 | -5.17 Mn |
| Jun 30, 2022 | -4.56 Mn |
| Mar 31, 2022 | -4.40 Mn |
| Dec 31, 2021 | -4.47 Mn |
Grace Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();